These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35617799)

  • 1. A magnetoimpedance biosensor microfluidic platform for detection of glial fibrillary acidic protein in blood for acute stroke classification.
    Sayad A; Uddin SM; Yao S; Wilson H; Chan J; Zhao H; Donnan G; Davis S; Skafidas E; Yan B; Kwan P
    Biosens Bioelectron; 2022 Sep; 211():114410. PubMed ID: 35617799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial Fibrillary Acidic Protein for Prehospital Diagnosis of Intracerebral Hemorrhage.
    Rozanski M; Waldschmidt C; Kunz A; Grittner U; Ebinger M; Wendt M; Winter B; Bollweg K; Villringer K; Fiebach JB; Audebert HJ
    Cerebrovasc Dis; 2017; 43(1-2):76-81. PubMed ID: 27951536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.
    Foerch C; Niessner M; Back T; Bauerle M; De Marchis GM; Ferbert A; Grehl H; Hamann GF; Jacobs A; Kastrup A; Klimpe S; Palm F; Thomalla G; Worthmann H; Sitzer M;
    Clin Chem; 2012 Jan; 58(1):237-45. PubMed ID: 22125303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of serum glial fibrillary acidic protein test as a promising tool for intracerebral hemorrhage diagnosis in Chinese patients and prediction of the short-term functional outcomes.
    Xiong L; Yang Y; Zhang M; Xu W
    Neurol Sci; 2015 Nov; 36(11):2081-7. PubMed ID: 26194533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Glial Fibrillary Acidic Protein in the Differential Diagnosis of Intracerebral Hemorrhage.
    Katsanos AH; Makris K; Stefani D; Koniari K; Gialouri E; Lelekis M; Chondrogianni M; Zompola C; Dardiotis E; Rizos I; Parissis J; Boutati E; Voumvourakis K; Tsivgoulis G
    Stroke; 2017 Sep; 48(9):2586-2588. PubMed ID: 28751552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomous electrochemical biosensing of glial fibrillary acidic protein for point-of-care detection of central nervous system injuries.
    Salahandish R; Hassani M; Zare A; Haghayegh F; Sanati-Nezhad A
    Lab Chip; 2022 Apr; 22(8):1542-1555. PubMed ID: 35297932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glial fibrillary acidic protein as a biomarker in differentiating intracerebral haemorrhage from ischaemic stroke and stroke mimics: a meta-analysis.
    Kumar A; Misra S; Yadav AK; Sagar R; Verma B; Grover A; Prasad K
    Biomarkers; 2020 Feb; 25(1):1-8. PubMed ID: 31702405
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage.
    Llombart V; García-Berrocoso T; Bustamante A; Giralt D; Rodriguez-Luna D; Muchada M; Penalba A; Boada C; Hernández-Guillamon M; Montaner J
    J Neurochem; 2016 Jan; 136(2):416-24. PubMed ID: 26526443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke.
    Luger S; Jæger HS; Dixon J; Bohmann FO; Schaefer J; Richieri SP; Larsen K; Hov MR; Bache KG; Foerch C;
    Neurocrit Care; 2020 Aug; 33(1):39-48. PubMed ID: 32096121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial Fibrillary Acidic Protein Serum Levels Distinguish between Intracerebral Hemorrhage and Cerebral Ischemia in the Early Phase of Stroke.
    Luger S; Witsch J; Dietz A; Hamann GF; Minnerup J; Schneider H; Sitzer M; Wartenberg KE; Niessner M; Foerch C;
    Clin Chem; 2017 Jan; 63(1):377-385. PubMed ID: 27881450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke.
    Foerch C; Curdt I; Yan B; Dvorak F; Hermans M; Berkefeld J; Raabe A; Neumann-Haefelin T; Steinmetz H; Sitzer M
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):181-4. PubMed ID: 16174653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive Exdia TRF-LFIA for simultaneous quantification of GFAP and NT-proBNP in distinguishing ischemic and hemorrhagic stroke.
    Lee M; Rafiq Sayyed D; Kim H; Sanchez JC; Sik Hong S; Choi S; Kim H; Han E; Won Kang H; Min Kim J; Joan M; Kim H; Chae H; Park JM
    Clin Chim Acta; 2024 Apr; 557():117872. PubMed ID: 38471630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases.
    Mayer CA; Brunkhorst R; Niessner M; Pfeilschifter W; Steinmetz H; Foerch C
    PLoS One; 2013; 8(4):e62101. PubMed ID: 23626774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: Systematic review and meta-analysis of diagnostic test accuracy.
    Perry LA; Lucarelli T; Penny-Dimri JC; McInnes MD; Mondello S; Bustamante A; Montaner J; Foerch C; Kwan P; Davis S; Yan B
    Int J Stroke; 2019 Jun; 14(4):390-399. PubMed ID: 30303809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Glial Fibrillary Acidic Protein in Patient Plasma Using On-Chip Graphene Field-Effect Biosensors, in Comparison with ELISA and Single-Molecule Array.
    Xu L; Ramadan S; Akingbade OE; Zhang Y; Alodan S; Graham N; Zimmerman KA; Torres E; Heslegrave A; Petrov PK; Zetterberg H; Sharp DJ; Klein N; Li B
    ACS Sens; 2022 Jan; 7(1):253-262. PubMed ID: 34908400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial-fibrillary-acidic-protein (GFAP) biomarker detection in serum-matrix: Functionalization strategies and detection by an ultra-high-frequency surface-acoustic-wave (UHF-SAW) lab-on-chip.
    Agostini M; Amato F; Vieri ML; Greco G; Tonazzini I; Baroncelli L; Caleo M; Vannini E; Santi M; Signore G; Cecchini M
    Biosens Bioelectron; 2021 Jan; 172():112774. PubMed ID: 33160234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.
    Undén J; Strandberg K; Malm J; Campbell E; Rosengren L; Stenflo J; Norrving B; Romner B; Lindgren A; Andsberg G
    J Neurol; 2009 Jan; 256(1):72-7. PubMed ID: 19221847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoporous Carbon Immunosensor for Highly Accurate and Sensitive Clinical Detection of Glial Fibrillary Acidic Protein in Traumatic Brain Injury, Stroke, and Spinal Cord Injury.
    Khetani S; Salahandish R; Tabor JB; Chilvers M; Dukelow S; Ho C; Campbell C; Sen A; Debert CT; Sanati-Nezhad A
    ACS Biomater Sci Eng; 2023 Jun; 9(6):3556-3569. PubMed ID: 37067234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury.
    Schiff L; Hadker N; Weiser S; Rausch C
    Mol Diagn Ther; 2012 Apr; 16(2):79-92. PubMed ID: 22497529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke.
    Dvorak F; Haberer I; Sitzer M; Foerch C
    Cerebrovasc Dis; 2009; 27(1):37-41. PubMed ID: 19018136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.